## Management of CIN 1 **Key Point:** CIN 1 has a high rate of spontaneous regression (60–90% in young women) and does NOT require immediate excisional treatment. Conservative management with surveillance is the standard approach. ### CIN 1 Management Algorithm ```mermaid flowchart TD A[CIN 1 diagnosed on colposcopy]:::outcome --> B{Age and clinical factors?}:::decision B -->|Age < 25 years| C[Observation with repeat cytology<br/>at 12 and 24 months]:::action B -->|Age ≥ 25 years| D[HPV testing or repeat cytology<br/>at 12 months]:::action C --> E{Persistent CIN 1<br/>or abnormal result?}:::decision D --> E E -->|Yes| F[Excisional procedure<br/>LEEP/cold knife conization]:::action E -->|No| G[Return to routine<br/>screening]:::outcome ``` ### Rationale for Observation | Feature | CIN 1 | CIN 2/3 | |---------|-------|--------| | Spontaneous regression rate | 60–90% | 30–40% | | Progression to invasive cancer | <1% | 5–30% if untreated | | Recommended management | Observation/surveillance | Excisional treatment | | Follow-up interval | 12 months | Immediate excision | **High-Yield:** The 2019 ASCCP guidelines recommend observation (not excision) for CIN 1 in non-pregnant women, as most lesions regress spontaneously. Excision is reserved for persistent CIN 1 (>24 months) or progression to CIN 2/3. **Clinical Pearl:** In women aged <25 years, observation is particularly favored because of the even higher spontaneous regression rates and the desire to avoid unnecessary procedures that may increase obstetric morbidity in future pregnancies. **Warning:** Do NOT confuse CIN 1 management with CIN 2/3 — the latter requires immediate excisional treatment (LEEP or cold knife conization) regardless of age. 
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.